Author

Nan Yan

The University of Texas Southwestern Medical CenterORCID 0000-0002-0637-3989Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:host-pathogen & immune response· 1 Assay:imaging· 1

Frequent Co-Authors

Andreas MarxiD· 1 shared Baran D. SumeriD· 1 shared Devon JeltemaiD· 1 shared Gang HuangiD· 1 shared Ivan Rodriguez SiordiaiD· 1 shared Jan Orth· 1 shared Jian WangiD· 1 shared Jinming GaoiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Andreas MarxORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintJun 30, 2025

The IFN I response in tumor cells is shaped by PARP7-p300/CBP interactions through distinct loss- and gain-of-function mechanisms

Ivan Rodriguez Siordia, Sonja Rieth, Rory K. Morgan…·Michael Cohen

This paper identifies p300 and CBP as PARP7 substrates that regulate IFNβ through loss- and gain-of-function mechanisms in colorectal cancer cells.

3 citations

humanproteomics

𝕏 PostBluesky

ImmunologyScience ImmunologyPeer-reviewedFeb 16, 2024

STING Licensing of Type I Dendritic Cells Potentiates Antitumor Immunity

Jian Wang, Suxin Li, Maggie Wang…·Jinming Gao

A 'shock-and-lock' nanoparticle agonist activates STING in type 1 conventional dendritic cells to enhance antitumor immunity with associated biomarkers.

151 citationstop 1%

𝕏 PostBluesky